Information about Proxy Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0673.992.721

VAT liability
Yes
Established
07-04-2017
Last balance sheet year
2024
Company size
Small 1,7 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Proxy Pharma

2024 2023 2022 2021
Profit/Loss 8,200 -86 % 57,355 -28 % 79,265 49 % 53,194
Equity 29,362 -59 % 71,163 79 % 39,807 85 % 21,543
Gross margin 173,544 -8 % 189,045 -8 % 205,543 30 % 158,082
Employees 1.7 1.3 1.4 1.2

Publications from Proxy Pharma

Date Publication
08-07-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations, Appointments (FR)
22-01-2018 Miscellaneous (FR)
11-04-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Proxy Pharma?
The VAT number of Proxy Pharma is BE 0673.992.721.
Wat is the PEPPOL ID of Proxy Pharma?
The PEPPOL ID of Proxy Pharma is 0208:0673992721. Log in or start a free trial to see the full overview.
When was Proxy Pharma founded?
Proxy Pharma was founded on 07-04-2017.
What is the address of Proxy Pharma?
The current registered office of Proxy Pharma is located at Rue des Salamandres T.-la-G. 2, 1320 Beauvechain.
When was the last time Proxy Pharma filed their annual financial statements?
The most recent financial statements of Proxy Pharma were filed on 03-07-2025.
How many employees does Proxy Pharma have?
There are 1,7 FTEs working at Proxy Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Proxy Pharma?
At the time of its most recent financial statements, Proxy Pharma did not publish any turnover figures. Proxy Pharma reported a gross margin of €173,543.73.